PAtHways to Improved Care- PAH Reflections: COVID-19 and Health Disparities
In this series of short vlogs, you’ll hear leading pulmonologist Dr. Victor Tapson, Director, Pulmonary Vascular Disease Research at Cedars-Sinai Medical Center, discusses how the pandemic has impacted his patients with PAH. Dr. Tapson will review any changes in his approach to diagnosis and treatment and available evidence to reduce risks in PAH. Disparities in care and how these impact patients with PAH will be the focus of one of the vlogs. Because the patient plays such a critical role in shared decision-making, this activity will also include a future patient ambassador sharing their perspectives, experiences, and treatment goals.
PAH Patients and the Pandemic: Reducing Risk and Impact
Clinical CommentaryHas the pandemic impacted your patients with PAH? Have you changed your care of these patients? In this short CME-certified vlog, leading pulmonologist Dr. Victor Tapson, Director, Pulmonary Vascular Disease Research at Cedars-Sinai Medical Center, discusses how the pandemic has impacted his patients and reviews available evidence on reducing risks in PAH patients during the pandemic. He also touches on changes he has made in his approach to the diagnosis of PAH patients during the pandemic.
Faculty: Victor Tapson, MD
Release Date:
Expiration Date: May 17, 2022
CME/CE is no longer available for this activity
Treatment Considerations for PAH Patients During the Pandemic
Clinical Commentary
Are you taking the right precautions to ensure your patients with PAH are safely managed during COVID-19? Are you employing effective therapeutic management strategies with your PAH patients during the pandemic? In this short CME-certified vlog, leading pulmonologist Dr. Victor Tapson, Director, Pulmonary Vascular Disease Research at Cedars-Sinai Medical Center, discusses how to effectively manage therapy for PAH during the pandemic, including those who are COVID-19-infected, taking into account the evidence and guidelines to facilitate effective therapeutic management.
Faculty: Victor Tapson, MD
Release Date:
Expiration Date: May 28, 2022
CME/CE is no longer available for this activity
Reducing Healthcare Disparities for PAH Patients
Clinical CommentaryVery few studies have assessed the impact of healthcare disparities on PAH, despite the potential adverse impacts. One such study from Talwar et al reported that minority PAH patients may be at risk for worse outcomes due to lack of healthcare access, insurance gaps, and socioeconomic status. Dr. Victor Tapson, Director, Pulmonary Vascular Disease Research at Cedars-Sinai Medical Center, draws from his own experience of treating PAH patients and shares how increased awareness and education can improve outcomes for all patients.
Faculty: Victor Tapson, MD
Release Date:
Expiration Date: June 11, 2022
CME/CE is no longer available for this activity
PAH and COVID-19: A Patient’s Journey
Symposium HighlightsPAH patient and advocate, Jen, shares her perspective, experience, and challenges with managing her PAH every day and during her COVID-19 infection. Learn from her journey and consider how her experiences may improve your own PAH patients’ outcomes.
Faculty: Jen C. (PAH Patient & Advocate)
Release Date:
Expiration Date: June 28, 2022
CME/CE is no longer available for this activity
